+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Genetically Modified Experimental Animal Model Market - Global Forecast 2026-2032- Product Image
Genetically Modified Experimental Animal Model Market - Global Forecast 2026-2032- Product Image
Sale

Genetically Modified Experimental Animal Model Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6141586
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Genetically Modified Experimental Animal Model Market is projected to reach USD 2.48 Billion in 2026. It is expected to continue growing at a CAGR of 12.49%, reaching USD 5.01 Billion by 2032.

Genetically Modified Experimental Animal Models: Executive Overview

Genetically modified experimental animal models are engineered organisms used to investigate gene function, disease mechanisms, therapeutic responses, and safety. The field spans targeted gene disruption, transgenic expression, conditional alleles, humanized models, genome editing, and increasingly sophisticated multi-omic characterization. Use is concentrated in biomedical research, drug discovery, toxicology, immunology, oncology, neuroscience, metabolic disease, and rare-disease studies.

From Conventional Transgenics to Precision, Human-Relevant Models

The landscape is shifting from broadly engineered strains toward models designed around specific biological questions and translational needs. CRISPR-based editing, conditional control of gene activity, precise knock-in methods, and humanized immune or tissue systems are improving experimental resolution. At the same time, researchers are placing greater emphasis on reproducibility, genetic background, standardized phenotyping, welfare, and alignment between model selection and clinical biology.

Artificial Intelligence Is Connecting Design, Phenotyping, and Interpretation

Artificial intelligence is influencing the field through genomic target prioritization, sequence design, phenotype classification, image analysis, and integration of high-dimensional molecular data. Machine-learning systems can help identify candidate edits, detect subtle behavioral or pathological patterns, and organize evidence across experiments. Their value remains dependent on representative training data, transparent validation, careful control of confounding variables, and expert review of biological plausibility.

Regional Insights: Diverse Regulatory and Research Environments

North America combines advanced biomedical infrastructure, translational research capacity, and established animal-care oversight. Europe emphasizes harmonized standards, ethical review, refinement, and alternatives, with the European Union supporting cross-border scientific coordination. Asia-Pacific is expanding capabilities in genome editing, breeding, phenotyping, and pharmaceutical research, particularly across Japan, China, South Korea, India, and Australia. Latin America is strengthening research networks and local laboratory capacity, while regulatory and infrastructure conditions vary across countries. The Middle East is developing life-science and biotechnology capabilities, often through institutional investment and international partnerships. Africa remains heterogeneous, with growing interest in locally relevant disease models alongside persistent constraints in specialized facilities, funding, and technical workforce development.

Group Insights: Cooperation Shapes Access, Standards, and Translation

ASEAN countries present a varied combination of emerging biotechnology capacity, university-led research, and developing regulatory systems. BRICS members contribute substantial scientific, pharmaceutical, and agricultural research capabilities, although infrastructure and oversight differ considerably. The European Union provides a framework for coordinated research and animal-welfare governance. G7 members generally combine mature biomedical ecosystems with rigorous compliance expectations. GCC countries are investing in research infrastructure, health innovation, and international collaboration. NATO members span a broad set of research environments, creating opportunities for shared standards and translational cooperation while retaining distinct national requirements.

Country Insights: Capabilities Differ by Research Focus and Governance

The United States and Canada have broad capabilities across model generation, contract research, biomedical discovery, and translational development. The United Kingdom, Germany, France, Italy, and Spain maintain strong academic, clinical, and pharmaceutical research ecosystems shaped by detailed welfare and regulatory requirements. China has expanded genome-editing, biomedical, and breeding capabilities, while Japan and South Korea are recognized for advanced life-science infrastructure and precision research. India is developing rapidly through pharmaceutical, academic, and biotechnology activity. Australia combines strong biomedical research with robust animal ethics oversight. Brazil and Mexico are building regional capacity, while Russia retains scientific capabilities alongside constraints related to access, collaboration, and research infrastructure.

Priorities for Leaders: Build Reproducible, Ethical, and Translational Programs

Leaders should select models against clearly defined biological and clinical objectives rather than novelty alone. Programs should document genetic background, editing validation, colony management, phenotyping protocols, and exclusion criteria, while using independent replication where feasible. Investment in standardized data capture, interoperable metadata, and AI systems with auditable validation can improve interpretation. Organizations should also strengthen welfare-by-design practices, preregister key experimental decisions when appropriate, develop alternatives such as organoids and computational models, and establish cross-functional governance spanning scientists, veterinarians, statisticians, ethicists, and regulatory specialists.

Methodology: Structured Synthesis of Scientific, Regulatory, and Geographic Evidence

This executive summary uses a qualitative synthesis framework focused on the definition, applications, enabling technologies, regional conditions, organizational groupings, and country-level capabilities associated with genetically modified experimental animal models. Evidence should be assessed across peer-reviewed literature, public regulatory guidance, institutional documentation, animal-welfare standards, technology publications, and independently verifiable scientific sources. Findings are interpreted comparatively and avoid unsupported numerical claims, market estimates, company-specific assertions, and projections. Geographic and group insights reflect differences in research infrastructure, governance, collaboration, and adoption conditions rather than a ranking of jurisdictions.

Conclusion: Precision and Responsibility Will Define the Next Phase

Genetically modified experimental animal models remain important tools for connecting molecular mechanisms with disease biology and therapeutic development. Their future relevance will depend less on engineering complexity alone than on human relevance, reproducibility, ethical rigor, and the quality of linked data. Institutions that combine precise model design, transparent validation, responsible AI, strong welfare practices, and regionally informed collaboration will be better positioned to produce findings that translate reliably into biomedical progress.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Genetically Modified Experimental Animal Model Market, by Service Type
7.1. Introduction
7.2. Genetic Screening Service
7.3. Model Generation Service
7.4. Phenotyping Service
7.5. Regulatory Compliance Service
8. Genetically Modified Experimental Animal Model Market, by Animal Model Type
8.1. Introduction
8.2. Mouse
8.3. Rabbit
8.4. Rat
8.5. Zebrafish
9. Genetically Modified Experimental Animal Model Market, by Genetic Modification Technology
9.1. Introduction
9.2. CRISPR/Cas9
9.2.1. CRISPR Activation
9.2.2. CRISPR Knockin
9.2.3. CRISPR Knockout
9.3. RNAi
9.4. TALENs
9.5. Zinc Finger Nucleases
10. Genetically Modified Experimental Animal Model Market, by Disease Area
10.1. Introduction
10.2. Cardiovascular
10.3. Immunology
10.4. Metabolic Disorders
10.5. Neurology
10.6. Oncology
11. Genetically Modified Experimental Animal Model Market, by End User
11.1. Introduction
11.2. Academic And Research Institutes
11.3. Contract Research Organizations
11.4. Hospitals And Clinical Labs
11.5. Pharmaceutical And Biotechnology Companies
12. Genetically Modified Experimental Animal Model Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Genetically Modified Experimental Animal Model Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Genetically Modified Experimental Animal Model Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Applied StemCell, Inc.
16.2. Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
16.3. BioIVT LLC
16.4. Biomodels, LLC
16.5. Biosidus S.A.
16.6. Charles River Laboratories International, Inc.
16.7. Crown Bioscience, Inc.
16.8. Cyagen Biosciences, Inc.
16.9. Envigo RMS LLC
16.10. GemPharmatech Co., Ltd.
16.11. GenOway S.A.
16.12. Horizon Discovery Group plc
16.13. Ingenious Targeting Laboratory
16.14. InVivo Biosystems
16.15. Janvier Labs
16.16. Laboratory Corporation of America Holdings
16.17. Ozgene Pty Ltd
16.18. Pharmaron, Inc.
16.19. PolyGene AG
16.20. SAGE Labs, Inc.
16.21. Shanghai Model Organisms Center, Inc.
16.22. Taconic Biosciences, Inc.
16.23. The Jackson Laboratory
16.24. Trans Genic Inc.
16.25. Yecuris Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Genetically Modified Experimental Animal Model Market, Years Considered for the Study
FIGURE 2. Global Genetically Modified Experimental Animal Model Market, Research Design
FIGURE 3. Global Genetically Modified Experimental Animal Model Market, Research Framework
FIGURE 4. Global Genetically Modified Experimental Animal Model Market, Data Triangulation
FIGURE 5. Global Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Genetically Modified Experimental Animal Model Market Size, by Service Type, 2025 vs 2032 (%)
FIGURE 7. Global Genetically Modified Experimental Animal Model Market Size, by Service Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2025 vs 2032 (%)
FIGURE 9. Global Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2025 vs 2032 (%)
FIGURE 11. Global Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2025 vs 2032 (%)
FIGURE 13. Global Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Genetically Modified Experimental Animal Model Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Genetically Modified Experimental Animal Model Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Genetically Modified Experimental Animal Model Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Genetically Modified Experimental Animal Model Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Genetically Modified Experimental Animal Model Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Genetically Modified Experimental Animal Model Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Genetically Modified Experimental Animal Model Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Genetically Modified Experimental Animal Model Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Genetically Modified Experimental Animal Model Market Segmentation & Coverage
TABLE 2. Global Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 3. Global Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 4. Global Genetic Screening Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Genetic Screening Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Genetic Screening Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Model Generation Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Model Generation Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Model Generation Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Phenotyping Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Phenotyping Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Phenotyping Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Regulatory Compliance Service Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Regulatory Compliance Service Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Regulatory Compliance Service Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 17. Global Mouse Market Size, by Region, 2017-2032 (USD Million)
TABLE 18. Global Mouse Market Size, by Group, 2017-2032 (USD Million)
TABLE 19. Global Mouse Market Size, by Country, 2017-2032 (USD Million)
TABLE 20. Global Rabbit Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Rabbit Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Rabbit Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Rat Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Rat Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Rat Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Zebrafish Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Zebrafish Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Zebrafish Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 30. Global CRISPR/Cas9 Market Size, by Region, 2017-2032 (USD Million)
TABLE 31. Global CRISPR/Cas9 Market Size, by Group, 2017-2032 (USD Million)
TABLE 32. Global CRISPR/Cas9 Market Size, by Country, 2017-2032 (USD Million)
TABLE 33. Global CRISPR Activation Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global CRISPR Activation Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global CRISPR Activation Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global CRISPR Knockin Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global CRISPR Knockin Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global CRISPR Knockin Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global CRISPR Knockout Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global CRISPR Knockout Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global CRISPR Knockout Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global RNAi Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global RNAi Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global RNAi Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global TALENs Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global TALENs Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global TALENs Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Zinc Finger Nucleases Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Zinc Finger Nucleases Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Zinc Finger Nucleases Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 52. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Immunology Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Immunology Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Immunology Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Metabolic Disorders Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Metabolic Disorders Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Metabolic Disorders Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 63. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 64. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 66. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 67. Global Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Hospitals And Clinical Labs Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Hospitals And Clinical Labs Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Hospitals And Clinical Labs Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Pharmaceutical And Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Pharmaceutical And Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Pharmaceutical And Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Genetically Modified Experimental Animal Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Asia-Pacific Genetically Modified Experimental Animal Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Asia-Pacific Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 83. Asia-Pacific Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 84. Asia-Pacific Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 85. Asia-Pacific Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 86. Asia-Pacific Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 87. Asia-Pacific Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 88. North America Genetically Modified Experimental Animal Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. North America Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 90. North America Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 91. North America Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 92. North America Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 93. North America Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 94. North America Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Latin America Genetically Modified Experimental Animal Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Latin America Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 97. Latin America Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 98. Latin America Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 99. Latin America Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 100. Latin America Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 101. Latin America Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. Europe Genetically Modified Experimental Animal Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Europe Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 104. Europe Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 105. Europe Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 106. Europe Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 107. Europe Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 108. Europe Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. Middle East Genetically Modified Experimental Animal Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Middle East Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 111. Middle East Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 112. Middle East Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 113. Middle East Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 114. Middle East Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 115. Middle East Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. Africa Genetically Modified Experimental Animal Model Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Africa Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 118. Africa Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 119. Africa Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 120. Africa Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 121. Africa Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 122. Africa Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. Global Genetically Modified Experimental Animal Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. ASEAN Genetically Modified Experimental Animal Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. ASEAN Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 126. ASEAN Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 127. ASEAN Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 128. ASEAN Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 129. ASEAN Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 130. ASEAN Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 131. GCC Genetically Modified Experimental Animal Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 132. GCC Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 133. GCC Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 134. GCC Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 135. GCC Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 136. GCC Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 137. GCC Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 138. European Union Genetically Modified Experimental Animal Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 139. European Union Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 140. European Union Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 141. European Union Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 142. European Union Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 143. European Union Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 144. European Union Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. BRICS Genetically Modified Experimental Animal Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. BRICS Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 147. BRICS Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 148. BRICS Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 149. BRICS Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 150. BRICS Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 151. BRICS Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. G7 Genetically Modified Experimental Animal Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. G7 Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 154. G7 Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 155. G7 Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 156. G7 Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 157. G7 Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 158. G7 Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. NATO Genetically Modified Experimental Animal Model Market Size, by Group, 2017-2032 (USD Million)
TABLE 160. NATO Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 161. NATO Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 162. NATO Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 163. NATO Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 164. NATO Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 165. NATO Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. Global Genetically Modified Experimental Animal Model Market Size, by Country, 2017-2032 (USD Million)
TABLE 167. United States Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 168. United States Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 169. United States Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 170. United States Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 171. United States Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 172. United States Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 173. United States Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Canada Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 175. Canada Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 176. Canada Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 177. Canada Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 178. Canada Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 179. Canada Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 180. Canada Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Mexico Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 182. Mexico Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 183. Mexico Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 184. Mexico Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 185. Mexico Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 186. Mexico Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 187. Mexico Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 188. Brazil Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 189. Brazil Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 190. Brazil Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 191. Brazil Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 192. Brazil Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 193. Brazil Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 194. Brazil Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 195. United Kingdom Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 196. United Kingdom Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 197. United Kingdom Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 198. United Kingdom Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 199. United Kingdom Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 200. United Kingdom Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 201. United Kingdom Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. Germany Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 203. Germany Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 204. Germany Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 205. Germany Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 206. Germany Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 207. Germany Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 208. Germany Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. France Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 210. France Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 211. France Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 212. France Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 213. France Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 214. France Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 215. France Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Russia Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 217. Russia Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 218. Russia Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 219. Russia Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 220. Russia Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 221. Russia Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 222. Russia Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. Italy Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 224. Italy Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 225. Italy Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 226. Italy Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 227. Italy Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 228. Italy Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 229. Italy Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Spain Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 231. Spain Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 232. Spain Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 233. Spain Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 234. Spain Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 235. Spain Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 236. Spain Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 237. China Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 238. China Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 239. China Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 240. China Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 241. China Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 242. China Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 243. China Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 244. India Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 245. India Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 246. India Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 247. India Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 248. India Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 249. India Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 250. India Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 251. Japan Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 252. Japan Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 253. Japan Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 254. Japan Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 255. Japan Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 256. Japan Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 257. Japan Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 258. Australia Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 259. Australia Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 260. Australia Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 261. Australia Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 262. Australia Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 263. Australia Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 264. Australia Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 265. South Korea Genetically Modified Experimental Animal Model Market Size, 2017-2032 (USD Million)
TABLE 266. South Korea Genetically Modified Experimental Animal Model Market Size, by Service Type, 2017-2032 (USD Million)
TABLE 267. South Korea Genetically Modified Experimental Animal Model Market Size, by Animal Model Type, 2017-2032 (USD Million)
TABLE 268. South Korea Genetically Modified Experimental Animal Model Market Size, by Genetic Modification Technology, 2017-2032 (USD Million)
TABLE 269. South Korea Genetically Modified Experimental Animal Model Market Size, by CRISPR/Cas9, 2017-2032 (USD Million)
TABLE 270. South Korea Genetically Modified Experimental Animal Model Market Size, by Disease Area, 2017-2032 (USD Million)
TABLE 271. South Korea Genetically Modified Experimental Animal Model Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. Global Genetically Modified Experimental Animal Model Market Share, by Key Player, 2025
TABLE 273. Global Genetically Modified Experimental Animal Model Market, Key Experts

Companies Mentioned

  • Applied StemCell, Inc.
  • Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
  • BioIVT LLC
  • Biomodels, LLC
  • Biosidus S.A.
  • Charles River Laboratories International, Inc.
  • Crown Bioscience, Inc.
  • Cyagen Biosciences, Inc.
  • Envigo RMS LLC
  • GemPharmatech Co., Ltd.
  • GenOway S.A.
  • Horizon Discovery Group plc
  • Ingenious Targeting Laboratory
  • InVivo Biosystems
  • Janvier Labs
  • Laboratory Corporation of America Holdings
  • Ozgene Pty Ltd
  • Pharmaron, Inc.
  • PolyGene AG
  • SAGE Labs, Inc.
  • Shanghai Model Organisms Center, Inc.
  • Taconic Biosciences, Inc.
  • The Jackson Laboratory
  • Trans Genic Inc.
  • Yecuris Corporation

Related Topics

Related Reports

Transgenic Animal Model Market - A Global and Regional Analysis: Focus on Technology, Animal Type, Application, End User, and Regional Analysis - Analysis and Forecast, 2025-2035 - Product Image

Transgenic Animal Model Market - A Global and Regional Analysis: Focus on Technology, Animal Type, Application, End User, and Regional Analysis - Analysis and Forecast, 2025-2035

  • Report
  • 164 Pages
  • Global
From
Animal Model Market - Global Forecast 2026-2032 - Product Image

Animal Model Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Animal Model - Global Strategic Business Report - Product Image

Animal Model - Global Strategic Business Report

  • Report
  • 383 Pages
  • Global
From
Animal Model Market Report 2026 - Product Image

Animal Model Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Animal Model - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Animal Model - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 130 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.